DexCom has had a rough ride this year. The medical technology company is grappling with concerns about its slowing growth and allegations of faulty blood glucose monitors. However, DexCom is “already ...

Wondering if DexCom stock is a hidden bargain or just riding a wave? You are not alone, and today's market swings only add to the intrigue. DexCom shares have jumped 5.4% over the past week even after ...

A new type of sensor that levitates dozens of glass microparticles could revolutionize the accuracy and efficiency of sensing, laying the foundation for better autonomous vehicles, navigation and even ...

LOS ANGELES, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of §§10(b) ...

One of the most respected players in the BEV space, XPENG prepares to launch the refreshed G6 electric sport utility vehicle in the United Kingdom. Coming in the first quarter of next year with a ...

DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning ...

As previously reported, Morgan Stanley upgraded DexCom (DXCM) to Overweight from Equal Weight with a price target of $75, up from $63, citing signs that the company is already turning the corner from ...

Investors encouraged to join DexCom class action lawsuit. Allegations include unapproved design changes to G6/G7 glucose ...

DexCom has been in for a rough ride this year. The medical technology company is grappling with concerns over its slowing growth and allegations of faulty blood glucose monitors.

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...